Related Experiment Video
Updated: Jun 13, 2025

08:42
Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
4.4K
Functional Insights in PLS3-Mediated Osteogenic Regulation
Wenchao Zhong1,2,3,4, Janine Neugebauer5,6, Janak L Pathak4
1Department of Human Genetics, Amsterdam UMC Location Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.
Cells
|September 14, 2024
Summary
Plastin-3 (PLS3) deficiency causes bone fragility. While other actin proteins partially compensate, PLS3
Area of Science:
- Cell Biology
- Genetics
- Biochemistry
Background:
- Plastin-3 (PLS3) is an actin-bundling protein crucial for cellular processes.
- Genetic defects in PLS3 lead to X-linked osteoporosis and childhood fractures.
- The precise molecular mechanisms underlying PLS3-related bone disorders are not fully understood.
Purpose of the Study:
- To investigate the functional compensation of Plastin-3 (PLS3) by other actin-bundling proteins.
- To explore the molecular etiology of PLS3-related bone pathologies.
- To identify global gene expression changes and affected pathways following PLS3 knockdown.
Main Methods:
- Morpholino-mediated knockdown of *pls3* in zebrafish.
- Analysis of primary dermal fibroblasts from patients with *PLS3* variants during osteogenic differentiation.
- RNA sequencing (RNA-seq) of murine MLO-Y4 cells following *Pls3* knockdown.
Main Results:
- ACTN1 and ACTN4 partially rescued skeletal deformities in zebrafish lacking PLS3, while FSCN1 did not.
- Fibroblasts from patients with *PLS3* variants exhibited normal osteogenic differentiation.
- PLS3 knockdown in MLO-Y4 cells altered expression of genes involved in Wnt and Th17 cell differentiation pathways, with increased WNT2 in patient cells.
Conclusions:
- Functional compensation by actin-bundling proteins is insufficient to fully rescue PLS3-deficiency phenotypes.
- PLS3-related bone pathology involves broader molecular pathways beyond actin-bundling.
- The findings implicate altered Wnt signaling and Th17 cell differentiation in the pathogenesis of PLS3-related bone disorders.
Related Concept Videos
Hormones and Bone Tissue
2.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.6K
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Bone Remodeling
38.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.2K

